+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2020 - Product Thumbnail Image

Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 35 Pages
  • Global
From
Dyslipidemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Dyslipidemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 345 Pages
  • Global
From
Ischemia Reperfusion Injury - Pipeline Review, H2 2020 - Product Thumbnail Image

Ischemia Reperfusion Injury - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 197 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more